Mirum Pharmaceuticals, Inc. (08D.F)
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
96.10+0.05%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+124.5%
The outlook
Mirum Pharmaceuticals, Inc. currently reads as bullish based on above its 50- & 200-day averages, 79% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Market cap
$5.86B
52-wk high
110.35
52-wk low
42.80
50-day avg
92.82
200-day avg
77.34
Trailing P/E
—